Cell Therapy News Volume 23.14 | May 2 2022

    0
    34






    2022-05-02 | CTN 23.14


    Cell Therapy News by STEMCELL Technologies
    Vol. 23.14 – 2 May, 2022
    TOP STORY

    Single-Cell RNA Sequencing Identified Novel Nr4a1+ Ear2+ Anti-inflammatory Macrophage Phenotype under Myeloid-TLR4 Dependent Regulation in Anti-glomerular Basement Membrane (GBM) Crescentic Glomerulonephritis (cGN)

    Single-cell RNA sequencing, pseudotime trajectories reconstruction, and motif enrichment analysis were used, and macrophage diversity in anti-GBM cGN under tight regulation of myeloid-TLR4 was uncovered.
    [Advanced Science]

    Full Article

    Tips to prepare for your next conference or networking event
    PUBLICATIONSRanked by the impact factor of the journal

    Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data Reveals a Pan-Cancer Stemness Signature Predicting Immunotherapy Response

    Investigators revealed a robust link between cancer stemness and immunotherapy resistance and developed a promising signature, Stem.Sig, which showed increased performance in comparison to other signatures regarding immune checkpoint inhibitor response prediction.
    [Genome Medicine]

    Full Article

    Enhanced AC133-Specific CAR T Cell Therapy Induces Durable Remissions in Mice with Metastatic Small Cell Lung Cancer

    Scientists studied the effectiveness of AC133-specific CAR T cells post-chemotherapy using human primary small cell lung cancer and an orthotopic xenograft mouse model.
    [Cancer Letters]

    Abstract

    Phenotypic and Functional Characterization of the CD6-ALCAM T Cell Costimulatory Pathway after Allogeneic Cell Transplantation

    Researchers examined the expression of CD6 by reconstituting T cells in 95 patients after allogeneic cell transplantation and evaluated the effects of itolizumab, an anti-CD6 monoclonal antibody, on T cell activation.
    [Haematologica]

    Abstract

    A Novel Adoptive Synthetic TCR and Antigen Receptor (STAR) T Cell Therapy for B Cell Acute Lymphoblastic Leukemia

    Scientists developed a T cell receptor (TRC) complex-based CAR named STAR. They reported pre-clinical and phase I clinical trial data of this T cell therapy for refractory and relapsed B cell acute lymphoblastic leukemia patients.
    [American Journal of Hematology]

    Abstract

    MEX3A Promotes Nasopharyngeal Carcinoma Progression via the miR-3163/SCIN Axis by Regulating NF-κB Signaling Pathway

    Mex-3 RNA Binding Family Member A (MEX3A) depletion led to decreased cell proliferation, invasion, and migration, but increased apoptosis in nasopharyngeal carcinoma cells in vitro, while inhibiting tumor growth in vivo.
    [Cell Death & Disease]

    Full Article

    Autologous Hematopoietic Stem Cell Transplantation Promotes Connective Tissue Remodeling in Systemic Sclerosis Patients

    Researchers suggested that the therapeutic effects of autologous hematopoietic stem cell transplantation on skin fibrosis were related to changes in molecules associated with connective tissue maintenance and inflammation in systemic sclerosis.
    [Arthritis Research & Therapy]

    Full Article

    Pressure Increases PD-L1 Expression in A549 Lung Adenocarcinoma Cells and Causes Resistance to Anti-ROR1 CAR T Cell-Mediated Cytotoxicity

    Scientists constructed αROR1-CAR T cells and co-cultured with A549 cells with and without elevated pressure. They then measured apoptosis and cell death by flow cytometry and luciferase activity. They also measured cytokine release by ELISA.
    [Scientific Reports]

    Full Article

    In Vivo Engraftment into the Cornea Endothelium Using Extracellular Matrix Shrink-Wrapped Cells

    Investigators developed a technique to shrink-wrap micropatterned islands of corneal endothelial cells in a basement membrane-like layer of extracellular matrix that enabled the cells to maintain their cell-cell junctions and cytoskeletal structure while in suspension.
    [Communications Materials]

    Full Article


    This webinar provides insights and techniques for efficient leukopak sample processing and streamlined cell isolation.
    REVIEWS

    Decellularization of Tumors: A New Frontier in Tissue Engineering

    That authors review the efforts into decellularization of tumors to date, which represents a new frontier in the ever evolving field of tumor tissue engineering.
    [Journal of Tissue Engineering]

    Full Article

    INDUSTRY AND POLICY NEWS

    VITRAC Therapeutics Initiates a Phase I/II Clinical Trial with the Aurora Kinase A inhibitor VIC-1911 in GVHD Prophylaxis

    VITRAC Therapeutics, LLC initiated a Phase I/II clinical trial of VIC-1911 in combination with sirolimus and post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in myeloablative allogeneic stem cell transplantation. 
    [VITRAC Therapeutics, LLC (BusinessWire, Inc.)]

    Press Release

    Cynata Starts Trials on Diabetic Foot Ulcer Treatment

    Stem cell biotechnology company Cynata Therapeutics has started clinical trials with an initial cohort of patients in Adelaide of its patented product, aimed at treating diabetic foot ulcers.
    [Cynata Therapeutics (The West Australian)]

    Press Release

    FEATURED EVENT

    AAI – Immunology 2022

    May 6 – 10, 2022
    Portland, Oregon, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Immuno-Oncology/Vascular Biology Research

    Johns Hopkins University School of Medicine – St. Petersburg, Florida, United States

    Postdoctoral Fellow – In Vitro Vascular Models

    European Molecular Biology Laboratory – Barcelona, Spain

    Research Associate – Molecular Biology

    The University of British Columbia – Vancouver, British Columbia, Canada

    Postdoctoral Researcher – Molecular Tissue/Organ Regeneration

    Helmholtz Munich – München, Germany

    Postdoctoral Scholarship – Epigenetics and Nuclear Organization

    Baylor College of Medicine – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter